In vivo MRI is sensitive to remyelination in a nonhuman primate model of multiple sclerosis
- National Institute of Neurological Disorders and Stroke, United States
- University of Pittsburgh, United States
- National Institute of Mental Health, United States
- Vertex Phamaceuticals Inc, United States
- Cedars-Sinai Medical Center, United States
Abstract
Remyelination is crucial to recover from inflammatory demyelination in multiple sclerosis (MS). Investigating remyelination in vivo using magnetic resonance imaging (MRI) is difficult in MS, where collecting serial short-interval scans is challenging. Using experimental autoimmune encephalomyelitis (EAE) in common marmosets, a model of MS that recapitulates focal cerebral inflammatory demyelinating lesions, we investigated whether MRI is sensitive to, and can characterize, remyelination. In 6 animals followed with multisequence 7-tesla MRI, 31 focal lesions, predicted to be demyelinated or remyelinated based on signal intensity on proton density-weighted images, were subsequently assessed with histopathology. Remyelination occurred in 4 of 6 marmosets and 45% of lesions. Radiological-pathological comparison showed that MRI had high statistical sensitivity (100%) and specificity (90%) for detecting remyelination. This study demonstrates the prevalence of spontaneous remyelination in marmoset EAE and the ability of in vivo MRI to detect it, with implications for preclinical testing of pro-remyelinating agents.
Data availability
All of the 6 marmosets' serial in vivo MRI images, including all the sequences used for analysis and figure generation, were uploaded in an easily accessible format (NIFTI). The file names are titled with the corresponding animal # used in the manuscript, as well as the date of MRI acquisition. All the Iba1 and PLP immunohistochemistry stains have been uploaded as well.
Article and author information
Author details
Funding
National Institutes of Health (Intramural Research Program)
- Nathanael J Lee
Adelson Family Foundation
- Maxime Donadieu
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: The study was performed under the guideline and in accordance with the National Institutes of Health IACUC. Specifically, the neuroethics committee of the National Institutes of Neurological Diseases and Stroke formally went through our manuscript prior to submission on salient topics including minimization of pain, justification of number of animals and the sex ratio, dosing of methylprednisone based on available human data. All procedures were performed under anesthesia to minimize discomfort and pain. Animals were housed in pairs or triplets to maximize social interactions and well-being. The institutional IACUC protocol number is #1308.
Copyright
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Metrics
-
- 1,227
- views
-
- 206
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Citations by DOI
-
- 3
- citations for umbrella DOI https://doi.org/10.7554/eLife.73786
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
In vivo MRI is sensitive to remyelination in a nonhuman primate model of multiple sclerosis
eLife 12:e73786.
https://doi.org/10.7554/eLife.73786
